The goal associated with these stated primary objectives is that """"""""important and novel research issues can be addressed which would not be possible with the resources available at any one center"""""""" and that these research activities, using the resources of the data coordination center, """"""""may be supported through the usual NIH and other federal and non-federal sources for funding investigator initiated applications"""""""". We have re-structured the stated objectives into Specific Aims for our proposed Alzheimer's Disease Data Coordinating Center: 1. To migrate, continue data flow, and maintain the existing Minimum Data Set (MDS) providing means of access to the centers, security and data quality control; 2. To use the MDS data to establish an auxiliary database which catalogs tissues and biological specimens available at participating ADCs; to describe numbers and types of specimens available and facilitate contact between investigators while maintaining data security and confidentiality; 3. To provide statistical and epidemiologic consulting concerning research questions, study designs, and analytic methods best suited to the MDS and the biologic specimen database; 4. To foster collaborative research among ADCs for research questions best addressed by """"""""expanded"""""""" data collection: to insure rigorous design/analysis standards for feasibility studies; to provide a mechanism for review and funding of Feasibility studies through the ADDCC in conjunction with the Steering Committee to require a hypothesis-driven approach to """"""""expanded"""""""", retrospective and prospective data collection; to formulate designs and analyses for important or novel research questions, as determined by the Steering Committee in conjunction with the ADC directors; 5. To participate in the expansion of successful feasibility studies toward ADC-wide (or consortium) initiatives which would be funded by other means; to provide consultation on the design and analysis of those studies to provide, as needed and as feasible, the 'core' statistical and database functions for those studies.

Agency
National Institute of Health (NIH)
Institute
National Institute on Aging (NIA)
Type
Research Project--Cooperative Agreements (U01)
Project #
5U01AG016976-04
Application #
6509658
Study Section
Special Emphasis Panel (ZAG1-DAG-1 (M1))
Program Officer
Phelps, Creighton H
Project Start
1999-07-01
Project End
2004-06-30
Budget Start
2002-07-15
Budget End
2003-06-30
Support Year
4
Fiscal Year
2002
Total Cost
$3,136,461
Indirect Cost
Name
University of Washington
Department
Public Health & Prev Medicine
Type
Schools of Public Health
DUNS #
135646524
City
Seattle
State
WA
Country
United States
Zip Code
98195
Kamara, Dennis M; Gangishetti, Umesh; Gearing, Marla et al. (2018) Cerebral Amyloid Angiopathy: Similarity in African-Americans and Caucasians with Alzheimer's Disease. J Alzheimers Dis 62:1815-1826
Kunutsor, Setor K; Laukkanen, Jari A; Burgess, Stephen (2018) Genetically elevated gamma-glutamyltransferase and Alzheimer's disease. Exp Gerontol 106:61-66
Davis, Matthew; O Connell, Thomas; Johnson, Scott et al. (2018) Estimating Alzheimer's Disease Progression Rates from Normal Cognition Through Mild Cognitive Impairment and Stages of Dementia. Curr Alzheimer Res 15:777-788
Khachaturian, Ara S; Hayden, Kathleen M; Mielke, Michelle M et al. (2018) Future prospects and challenges for Alzheimer's disease drug development in the era of the NIA-AA Research Framework. Alzheimers Dement 14:532-534
Scelsi, Marzia A; Khan, Raiyan R; Lorenzi, Marco et al. (2018) Genetic study of multimodal imaging Alzheimer's disease progression score implicates novel loci. Brain 141:2167-2180
Agogo, George O; Ramsey, Christine M; Gnjidic, Danijela et al. (2018) Longitudinal associations between different dementia diagnoses and medication use jointly accounting for dropout. Int Psychogeriatr 30:1477-1487
Kaur, Antarpreet; Edland, Steven D; Peavy, Guerry M (2018) The MoCA-Memory Index Score: An Efficient Alternative to Paragraph Recall for the Detection of Amnestic Mild Cognitive Impairment. Alzheimer Dis Assoc Disord 32:120-124
Nordestgaard, Liv Tybjærg; Tybjærg-Hansen, Anne; Rasmussen, Katrine Laura et al. (2018) Genetic variation in clusterin and risk of dementia and ischemic vascular disease in the general population: cohort studies and meta-analyses of 362,338 individuals. BMC Med 16:39
Brenowitz, Willa D; Han, Fang; Kukull, Walter A et al. (2018) Treated hypothyroidism is associated with cerebrovascular disease but not Alzheimer's disease pathology in older adults. Neurobiol Aging 62:64-71
Cleary, Ekaterina Galkina; Cifuentes, Manuel; Grinstein, Georges et al. (2018) Association of Low-Level Ozone with Cognitive Decline in Older Adults. J Alzheimers Dis 61:67-78

Showing the most recent 10 out of 552 publications